Factor Xa inhibitor - Bio-Technology GeneralAlternative Names: Factorex
Latest Information Update: 09 Oct 2007
At a glance
- Originator American Red Cross; Yissum Research Development Company
- Developer Nonindustrial source; Savient Pharmaceuticals
- Mechanism of Action Factor Xa inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arterial occlusive disorders; Deep vein thrombosis; Thrombosis